The Disability, Outcome, and Cost (DOC) Unit seeks to advance research into schizophrenia-related disability through service functions to other Units of the IRC and associated R01s, as well as through pursuit of scientific aims. Investigators working with the DOC Unit will develop, disseminate and apply new methods for measuring disability and its neuropsychological/biological determinants, and perform economic evaluations of disability and the cost of treatment and support intervention. A key emphasis in the Unit is the longitudinal perspective on the study of disability and illness course, and the evaluation and clinical outcome in various environmental contexts. Service aims are to provide services to other IRC investigators and projects, including: (1) state-of-the-art services for intervention studies on the assessment of disability in a variety of life roles (work, independent living, socialization, parenting and other dependent care), the supports needed to maintain roles in these areas, and the costs related to disability; (2) developing infrastructure necessary to collect cost data and consultation for selecting disability, cost, and outcome measures; (3) training and supervision in functional assessment, service utilization, and cost instruments; and (4) mentoring for fellows and trainees. Scientific aims include: (1) develop new methods and procedures for assessment of disability and outcome, specifically through further testing and refinement of the Multi-dimensional Scale for Independent Functioning; (2) conduct analyses of data addressing the correlation of disability with brain structure/function, or data addressing the correlation of disability with brain structure/function, of data addressing the correlation of disability with brain structure/function, medication response, and side effects; (3) conduct studies to examine specific neuropsychological determinants of functional disabilities in various samples; (4) conduct economic evaluations within newly funded R01 grants; and (5) develop new methods for evaluating cost-utility.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH060575-02
Application #
6434456
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2001-02-01
Project End
2002-01-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
$175,212
Indirect Cost
Name
Long Island Jewish Medical Center
Department
Type
DUNS #
City
New Hyde Park
State
NY
Country
United States
Zip Code
11040
DeRosse, Pamela; Nitzburg, George C; Kompancaril, Bernie et al. (2014) The relation between childhood maltreatment and psychosis in patients with schizophrenia and non-psychiatric controls. Schizophr Res 155:66-71
Wellington, Robin L; Bilder, Robert M; Napolitano, Barbara et al. (2013) Effects of age on prefrontal subregions and hippocampal volumes in young and middle-aged healthy humans. Hum Brain Mapp 34:2129-40
Kane, John M; Kishimoto, Taishiro; Correll, Christoph U (2013) Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry. J Clin Epidemiol 66:S37-41
Ardekani, Babak A; Tabesh, Ali; Sevy, Serge et al. (2011) Diffusion tensor imaging reliably differentiates patients with schizophrenia from healthy volunteers. Hum Brain Mapp 32:1-9
Woerner, Margaret G; Correll, Christoph U; Alvir, Jose Ma J et al. (2011) Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-naïve patients. Neuropsychopharmacology 36:1738-46
Lencz, Todd; Robinson, Delbert G; Napolitano, Barbara et al. (2010) DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia. Pharmacogenet Genomics 20:569-72
Coscia, Denise M; Narr, Katherine L; Robinson, Delbert G et al. (2009) Volumetric and shape analysis of the thalamus in first-episode schizophrenia. Hum Brain Mapp 30:1236-45
Lencz, Todd; Lipsky, Robert H; DeRosse, Pamela et al. (2009) Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes. Br J Psychiatry 194:313-8
Szeszko, Philip R; Hodgkinson, Colin A; Robinson, Delbert G et al. (2008) DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia. Biol Psychol 79:103-10
Szeszko, Philip R; Robinson, Delbert G; Ashtari, Manzar et al. (2008) Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia. Neuropsychopharmacology 33:976-84

Showing the most recent 10 out of 44 publications